Rohini D'Souza

Title: Rohini D'Souza: Innovator in Neurological Therapeutics

Introduction

Rohini D'Souza is a prominent inventor based in Croton on Hudson, NY (US). She has made significant contributions to the field of neurological therapeutics, holding a total of four patents. Her work focuses on developing innovative solutions for treating neurological disorders.

Latest Patents

One of her latest patents is for "Sustained release compositions of 4-aminopyridine." This invention relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets are designed for once daily oral administration, aimed at treating neurological disorders. Another notable patent is "Proteoglycan degrading mutants for treatment of CNS." This disclosure involves the preparation and deletion mutants of chondroitinase proteins. These proteins are utilized in methods that promote the diffusion of therapeutic compositions into tissues, aiding in neurological functional recovery after central nervous system injury or disease.

Career Highlights

Rohini D'Souza is currently associated with Acorda Therapeutics, Inc., where she continues to advance her research and innovations. Her work has been instrumental in developing therapies that address critical needs in the field of neurology.

Collaborations

Throughout her career, Rohini has collaborated with notable colleagues, including Elliott A Gruskin and Gargi Roy. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Rohini D'Souza is a trailblazer in the field of neurological therapeutics, with a strong portfolio of patents that reflect her innovative spirit and dedication to improving patient outcomes. Her contributions are paving the way for new treatments in neurology.